deltatrials
Completed NCT00001858

Monitoring for Tolerance to Kidney or Combined Kidney-Pancreas Transplants

Monitoring for Donor-Specific Hyporesponsiveness Following Renal and Pancreatic Allotransplantation

Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Updated 25 times since 2017 Last updated: Dec 14, 2019 Started: Jun 8, 1999 Completion: May 30, 2014

A observational or N/A phase clinical study on Graft Rejection and Kidney Disease, this trial is completed. The trial is conducted by National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) and has accumulated 25 data snapshots since 1999. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Change History

25 versions recorded
  1. Sep 2024 — Present [monthly]

    Completed

  2. Jul 2024 — Sep 2024 [monthly]

    Completed

  3. Jan 2021 — Jul 2024 [monthly]

    Completed

  4. Jan 2020 — Jan 2021 [monthly]

    Completed

  5. Dec 2019 — Jan 2020 [monthly]

    Completed

Show 20 earlier versions
  1. Nov 2019 — Dec 2019 [monthly]

    Completed

  2. Oct 2019 — Nov 2019 [monthly]

    Completed

  3. Sep 2019 — Oct 2019 [monthly]

    Completed

  4. Aug 2019 — Sep 2019 [monthly]

    Completed

  5. Jul 2019 — Aug 2019 [monthly]

    Completed

  6. Jun 2019 — Jul 2019 [monthly]

    Completed

  7. May 2019 — Jun 2019 [monthly]

    Completed

  8. Apr 2019 — May 2019 [monthly]

    Completed

  9. Mar 2019 — Apr 2019 [monthly]

    Completed

  10. Feb 2019 — Mar 2019 [monthly]

    Completed

  11. Jan 2019 — Feb 2019 [monthly]

    Completed

  12. Dec 2018 — Jan 2019 [monthly]

    Completed

  13. Nov 2018 — Dec 2018 [monthly]

    Completed

  14. Oct 2018 — Nov 2018 [monthly]

    Completed

  15. Sep 2018 — Oct 2018 [monthly]

    Completed

  16. Aug 2018 — Sep 2018 [monthly]

    Completed

  17. Jul 2018 — Aug 2018 [monthly]

    Completed

  18. Jun 2018 — Jul 2018 [monthly]

    Completed

  19. Apr 2018 — Jun 2018 [monthly]

    Completed

    Phase: NANone

  20. Jan 2017 — Apr 2018 [monthly]

    Completed NA

    First recorded

Jun 1999

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Data source: National Institutes of Health Clinical Center (CC)

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

  • Bethesda, United States